We serve Chemical Name:2-(5-methylthiophen-2-yl)azepane CAS:527674-20-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(5-methylthiophen-2-yl)azepane
CAS.NO:527674-20-0
Synonyms:2-(5-methyl-2-thienyl)azepane;2-(5-METHYL-THIOPHEN-2-YL)-AZEPANE
Molecular Formula:C11H17NS
Molecular Weight:195.32400
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:40.27000
Exact Mass:195.10800
LogP:3.59000
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-(5-methyl-2-thienyl)azepane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(5-METHYL-THIOPHEN-2-YL)-AZEPANE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(5-METHYL-THIOPHEN-2-YL)-AZEPANE Use and application,2-(5-METHYL-THIOPHEN-2-YL)-AZEPANE technical grade,usp/ep/jp grade.
Related News: The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development. 2-(5-methylthiophen-2-yl)azepane manufacturer Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release. 2-(5-methylthiophen-2-yl)azepane supplier The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development. 2-(5-methylthiophen-2-yl)azepane vendor An active pharmaceutical ingredient (API) is a substance, or a mixture of ingredients, combined in the manufacture of a pharmaceutical or drug. 2-(5-methylthiophen-2-yl)azepane factory Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue.
